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Retinal capillary endothelial cellas to identify the uptake mechanism of γ-aminobutyric acid (GABA) via taurine
transporter (Slc6a6/TauT) and its relationship with GABA transport at the inner BRB. Rat Slc6a6/TauT-transfected
HeLa cells exhibited Na+-, Cl−-, and concentration-dependent [3H]GABA uptake with a Km of 1.5 mM. Taurine, β-
alanine, and GABA markedly inhibited Slc6a6/TauT-mediated uptake of [3H]GABA. The uptake of [3H]GABA by a
conditionally immortalized rat retinal capillary endothelial cell line (TR-iBRB2) was Na+-, Cl−-, and concentration-
dependent with aKm of 2.0 mM. This process wasmore potently inhibited by substrates of Slc6a6/TauT, taurine and
β-alanine, than those of GABA transporters, GABA and betaine. In the presence of taurine, there was competitive
inhibitionwith aKi of 74 μM. [3H]Taurine also exhibited competitive inhibitionwith aKi of 1.8mM in the presence of
GABA. In conclusion, rat Slc6a6/TauT has the ability to use GABA as a substrate and Slc6a6/TauT-mediated GABA
transport appears to be present at the inner BRB.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionRetinalγ-aminobutyric acid (GABA)plays a key role as an inhibitory
neurotransmitter [1]. The neurotransmitter actions of GABA in the
synaptic cleft are terminated by its reuptake by either pre-synaptic
neurons or nearby glial cells via GABA transporters [2]. Four GABA
transporters have been isolated and all of them belong to the family
of Na+- and Cl−-dependent neurotransmitter transporters: Slc6 [3].
Slc6a1, Slc6a11, Slc6a12, and Slc6a13, respectively, correspond to GABA
transporter (GAT)-1, GAT-3, betaine/GABA transporter (BGT)-1, and
GAT-2 in rats and GAT1, GAT4, GAT2, and GAT3 in mice.
The inner blood-retinal barrier (BRB) forms complex tight
junctions of retinal capillary endothelial cells to restrict non-speciﬁc
transport between the circulating blood and neural retina [4,5].
Transporters at the inner BRB are thought to play essential roles
in supplying nutrients and be also responsible for the efﬂux of
neurotransmitters and their metabolites from the retina to the
circulating blood for the maintenance of neural functions. Recently,
we reported that a member of the Slc6 transporter family, taurine
transporter (Slc6a6/TauT), is expressed in retinal capillary endothe-
lial cells and mediates the transport of taurine [6]. Although it has
been reported that transfection with rat Slc6a6/TauT in COS cells
did not enhance the uptake of [3H]GABA [7], rat Slc6a6/TauT is most
closely related to rat Slc6a11/GAT-3 and Slc6a13/GAT-2 (61% amino
acid identity) and it has been referred to an “honorary GABA
transporter” (for a review, see [8]). Consequently, Slc6a6/TauT at the81 76 434 5172.
oya).
ll rights reserved.inner BRB might play an important role in reducing the GABA con-
centration in the retinal interstitial ﬂuid.
The purpose of the present study was to clarify whether rat Slc6a6/
TauT recognizesGABAas a substrate using Slc6a6/TauT-overexpressing
cells. Furthermore, we investigated the GABA transport properties at
the inner BRB using a conditionally immortalized rat retinal capillary
endothelial cell line (TR-iBRB2) [5,9].
2. Materials and methods
2.1. Cell culture
TR-iBRB2 cells possess endothelial markers and facilitative glucose transporter 1
(GLUT1), P-glycoprotein, creatine transporter (Slc6a8/CRT), and L-type amino acid
transporter 1 (LAT1) which are expressed at the inner BRB in vivo [9–11]. Thus, TR-
iBRB2 cells maintain certain in vivo functions and are a suitable in vitro model for the
inner BRB. Dulbecco's modiﬁed Eagle's medium (DMEM) containing 100 U/mL
benzylpenicillin potassium, 100 μg/mL streptomycin sulfate, and 10% fetal bovine
serum (FBS; Moregate, Bulimbra, Australia) was used as the culture medium for TR-
iBRB2 cells. TR-iBRB2 cells were seeded onto rat tail collagen type I-coated tissue
culture plates (BD Biosciences, Bedford, MA, USA) and cultured at 33 °C in a hu-
midiﬁed atmosphere of 5% CO2/air. The permissive-temperature for TR-iBRB2 cell
culture is 33 °C due to the presence of temperature-sensitive SV 40 large T-antigen [9].
HeLa cells were cultured at 37 °C in a humidiﬁed atmosphere of 5% CO2/air. The
culture medium for HeLa cells consisted of DMEM supplemented with 100 U/mL
benzylpenicillin potassium, 100 μg/mL streptomycin sulfate, 25 mM D-glucose, and
10% FBS.
2.2. cDNA isolation and expression of rat taurine transporter (Slc6a6/TauT)
Total cellular RNA was prepared from TR-iBRB2 cells using an Rneasy Kit (Qiagen,
Hilden, Germany). Single-strand cDNA was made from total RNA by reverse transcrip-
tion (RT) using oligo dT primer. The polymerase chain reaction (PCR) was performed
with rat Slc6a6/TauT (GenBank accession number NM_017206) speciﬁc primers through
40 cycles of 94 °C for 30 s, 65 °C for 30 s, and 72 °C for 2 min. The sequences of speciﬁc
Fig. 1. Localization (A) and function (B and C) of Xpress-tagged rat Slc6a6/TauT in
transfected HeLa cells. (A) Immunostaining of Xpress-tagged rat Slc6a6/TauT-trans-
fected HeLa cells. Anti-Xpress antibody was used for immunostaining. Scale bar, 20 μm.
(B) Time-course of [3H]taurine (17 nM) uptake at 37 °C by rat Slc6a6/TauT-transfected
(closed circle) and mock-transfected (open circle) cells. (C) Na+- and Cl−-dependence of
[3H]taurine uptake by rat Slc6a6/TauT-transfected cells. [3H]Taurine (17 nM) uptake by
rat Slc6a6/TauT-transfected cells was performed in the presence (control) or absence of
Na+ and Cl− at 37 °C for 5 min. Each point represents the mean±S.E.M. (n=4). ⁎pb0.01
signiﬁcantly different from control.
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(underlined) was 5′-GGA TCC ATG GCC ACC AAG GAG AAG CTT CA-3′ and the antisense
primer with an XhoI site (underlined) was 5′-CTC GAG TCA CAT CAT GGT CTC CAC AAT
GAC-3′. The PCR products were separated by electrophoresis on an agarose gel in the
presence of ethidium bromide and visualized under ultraviolet light. The PCR product at
1878 bp was then cloned into a pGEM-T Easy Vector (Promega, Madison, WI, USA) and
ampliﬁed in Escherichia coli. Several clones were then sequenced from both directions
using a DNA sequencer (ABI PRISM 310; Applied Biosystems, Foster City, CA, USA). The
cDNA segment 100% identical to the full-length of rat Slc6a6/TauT was cut from pGEM-T
Easy Vector using BamHI and XhoI (Roche, Mannheim, Germany), and subcloned into
pcDNA4/HisC vector (Invitrogen, Carlsbad, CA, USA), which contains Xpress epitope in
the upstream of the multiple cloning site.
Constructed pcDNA4/HisC/TauT or pcDNA4/HisC vector alone (termed mock) was
transfected into HeLa cells using Lipofectamine 2000 reagent (Invitrogen) according to the
manufacturer's protocol. Brieﬂy, HeLa cells were seeded at a density of 4×104 cells/cm2 on a
24-well tissue culture plate (BD Biosciences) or Lab-Tek chamber 8-well slide (Nalge Nunc,
Rochester, NY, USA). At 1 day after seeding, the cells were exposed to antibiotic-free DMEM
containing 25mM D-glucose and 10% FBS and then transfected with complexes of 1.0 μg/105
cells of pcDNA4/HisC/TauTorpcDNA4/HisC and1.9 μL/105 cells of Lipofectamine2000 reagent
inOPTI-MEMImedium(Invitrogen).At 6hafter the initiationof transfection, themediumwas
changed to antibiotic-free DMEM containing 25 mM D-glucose and 10% FBS.
2.3. Immunohistochemical analysis
pcDNA4/HisC/TauTormock-transfected HeLa cells were cultured on Lab-Tek chamber
8-well slides and ﬁxed with 4% paraformaldehyde in phosphate buffered saline (PBS) for
10minat roomtemperature. Cellswere incubatedwithmethanol containing5%acetic acid
and5%water for 10min at−20 °Cand then incubatedwith10%goat serum(Nichirei, Tokyo,
Japan) for 30min at room temperature. Cellswere then incubatedwithmousemonoclonal
anti-Xpress antibody (1:240; Invitrogen) for 16 h at 4 °C and subsequently incubatedwith
FITC-conjugated anti-mouse IgG antibody (1:200; Chemicon, Temecula, CA, USA) for 2 h at
room temperature. Photographs were taken with a confocal laser scanning microscope
(LSM 510; Carl Zeiss Meditec, Oberkochen, Germany).
2.4. [3H]GABA and [3H]taurine uptake
The 4-amino-n-[2,3-3H]butyric acid ([3H]GABA, 93.0 Ci/mmol, GE Healthcare Bio-
Sciences, Buckinghamshire, UK) or [2-3H(N)]taurine ([3H]taurine, 30.3 Ci/mmol, Perki-
nElmer Life Science, Boston,MA,USA) uptakewasmeasured according to a previous report
[6]. Brieﬂy, TR-iBRB2 cells and pcDNA4/HisC/TauT or mock-transfected HeLa cells were
cultured on24-well plates (BD Biosciences) andwashedwith 1mL extracellularﬂuid (ECF)
buffer consistingof 122mMNaCl, 25mMNaHCO3, 3mMKCl,1.4mMCaCl2,1.2mMMgSO4,
0.4mMK2HPO4,10mMD-glucose, and10mMHepes (pH7.4) at 37 °C.Uptakewas initiated
by applying 200 μL ECF buffer containing 0.2 μCi [3H]GABA (11 nM) or 0.1 μCi [3H]taurine
(17 nM) at 37 °C in the presence or absence of inhibitors. Na+- or Cl−-free ECF buffer were
obtained by replacement with equimolar choline or gluconate, respectively. After a
predetermined period, uptake was terminated by removing the solution, and cells were
washed with 1 mL ice-cold ECF buffer. The cells were then solubilized in 1 N NaOH and
subsequently neutralized. An aliquot was taken for measurement of radioactivity and
protein content using, respectively, a liquid scintillation counter and a DC protein assay kit
(Bio-rad, Hercules, CA, USA) with bovine serum albumin as a standard.
For kinetic studies, the Michaelis–Menten constant (Km) and maximum rate (Jmax)
of GABA or taurine uptakewere calculated from Eq. (1) using the nonlinear least-square
regression analysis program, MULTI [12].
J = Jmax  C= Km + Cð Þ ð1Þ
where J and C are the uptake rate of GABA or taurine and the concentration of GABA or
taurine, respectively. To analyze the mechanism of inhibition of [3H]GABA uptake by
taurine and [3H]taurine uptake by GABA, the inhibitory constant (Ki) was calculated
from Eq. (2) using MULTI [12].
J = Jmax  C= Km  1 + I=Kið Þ + C½  ð2Þ
where I is the concentration of GABA or taurine.
2.5. Data analysis
Unless otherwise indicated, all data represent means±S.E.M. An unpaired, two-tailed
Student's t-test was used to determine the signiﬁcance of differences between two groups.
Statistical signiﬁcance of differences amongmeans of several groupswas determined by one-
way analysis of variance followed by the modiﬁed Fisher's least-squares difference method.
3. Results
3.1. GABA uptake mediated by Slc6a6/TauT
Fig. 1A shows the confocal microscopic images of Xpress-tagged
Slc6a6/TauT-transfected HeLa cells stained with anti-Xpress antibody.Intense immunoreactivity was detected at the plasma membrane in
Slc6a6/TauT-transfected cells, whereas no signal was seen in the
mock-transfected cells (data not shown). The initial uptake rate of [3H]
taurine in Slc6a6/TauT-transfected cells was 3.6-fold greater than that
in mock-transfected cells (Fig. 1B). Moreover, the absence of either Na+
or Cl− reduced the Slc6a6/TauT-mediated uptake of [3H]taurine by
more than 90% (Fig. 1C). These results indicate that the introduced
Slc6a6/TauT acts at the plasma membrane in Slc6a6/TauT-transfected
cells.
The time-courses of [3H]GABA in Slc6a6/TauT- and mock-trans-
fected cells are shown in Fig. 2A. The initial uptake rate of [3H]GABA in
Slc6a6/TauT-transfected cells was 52.5 fmol/(min·mg protein) and 4.7-
fold greater than that in mock-transfected cells (11.2 fmol/(min·mg
Fig. 2. Time-course (A), Na+ and Cl−-dependence (B), and concentration-dependence (C)
of [3H]GABA uptake by rat Slc6a6/TauT-transfected cells. (A) Time-course of [3H]GABA
(11 nM) uptake at 37 °C by rat Slc6a6/TauT-transfected (closed circle) and mock-
transfected (open circle) cells. (B) [3H]GABA (11 nM) uptake was performed in the
presence (control) or absence of Na+ and Cl− at 37 °C for 10 min. (C) [3H]GABA (11 nM)
uptake was performed at 37 °C for 10 min. Km is 1.46±0.47 mM and Jmax is 666±
93 pmol/(min·mg protein) (mean±S.D.) according to Eq. (1). Each point represents the
mean±S.E.M. (n=4). ⁎pb0.01 signiﬁcantly different from control.
Table 2
Effect of several inhibitors on TauT-mediated [3H]GABA uptake by TauT-transfected
HeLa cells
Inhibitors Percentage of control
Control 100±3
2 mM taurine 3.80±1.31⁎
2 mM β-alanine 4.30±0.06⁎
2 mM γ-aminobutyric acid 28.7±4.5⁎
2 mM L-leucine 80.9±16.1
2 mM L-α-alanine 93.0±4.8
[3H]GABA uptake (11 nM) was performed in the absence (control) or presence of
inhibitors at 37 °C for 10 min. Each value represents the mean±S.E.M. (n=4–12).
⁎pb0.01, signiﬁcantly different from the control.
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substrate as well as taurine. The Slc6a6/TauT-mediated uptake of
GABA took place in a concentration-dependent manner (Fig. 2C).
Nonlinear, least-squares regression analysis was performed to give the
best ﬁt using the uptake rate for 10 min, yielding the following kineticTable 1
Km values for the uptake of GABA via Slc6 transporters
Transporters Km Species Reference
Slc6a1/GAT-1 7.0 μM Rat [13]
Slc6a6/TauT 1.5 mM Rat Fig. 2C
Slc6a11/GAT-3 2.3–12 μM Rat [14,15]
Slc6a12/GAT2 79 μM Mouse [16]
Slc6a13/GAT-2 8 μM Rat [15]parameters: a Km and Jmax of 1.46±0.47 mM and 666±93 pmol/
(min·mg protein) (mean±S.D.), respectively. This Km value is much
higher than those in other GABA transporters [13–16] (Table 1).Fig. 3. Time-course (A), Na+- and Cl−-dependence (B), and concentration-dependence
(C) of [3H]GABA uptake by TR-iBRB2 cells. (B) [3H]GABA (11 nM) uptake was performed
in the presence (control) or absence of Na+ and Cl− at 37 °C for 10 min. (C) [3H]GABA
(11 nM) uptake was performed at 37 °C for 10 min. Km is 2.04±0.33 mM and Jmax is 5.80±
0.53 nmol/(min·mg protein) (mean±S.D.) according to Eq. (1). Each point represents the
mean±S.E.M. (n=4). ⁎pb0.01 signiﬁcantly different from control.
Table 3
Effect of several inhibitors on [3H]GABA uptake by TR-iBRB2 cells
Inhibitors Percentage of control
Control 100±1
2 mM taurine 14.3±1.3⁎
2 mM β-alanine 16.4±2.1⁎
2 mM γ-aminobutyric acid 38.9±1.9⁎
500 μM nipecotic acid 83.2±4.5⁎
2 mM nipecotic acid 45.8±2.6⁎
2 mM betaine 86.3±3.2⁎
2 mM L-leucine 85.8±5.2⁎
2 mM L-α-alanine 70.5±2.8⁎
2 mM creatine 75.6±3.8⁎
2 mM probenecid 96.4±3.9
[3H]GABA uptake (11 nM) was performed in the absence (control) or presence of
inhibitors at 37 °C for 10 min. Each value represents the mean±S.E.M. (n=4–12).
⁎pb0.01, signiﬁcantly different from the control.
Fig. 4. Eadie–Scatchard plot of GABA (A) and taurine (B) uptake by TR-iBRB2 cells
showing mutual competitive inhibition of the uptake of taurine and GABA. (A) [3H]
GABA uptake was performed in the absence (closed circle) or presence of 50 μM taurine
(open circle) at 37 °C for 10 min. The Ki for taurine is 73.8±8.8 μM (mean±S.D.)
according to Eq. (2). (B) [3H]Taurine uptakewas performed in the absence (closed circle)
or presence of 5 mM GABA (open circle) at 37 °C for 5 min. The Ki for GABA is 1.80±
0.01 mM (mean±S.D.) according to Eq. (2). Each point represents the mean±S.E.M.
(n=4).
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examined the effects of several inhibitors of Slc6a6/TauT and other
compounds on Slc6a6/TauT-mediated uptake of [3H]GABA (Table 2).
Taurine, β-alanine, and GABA at a concentration of 2 mM markedly
inhibited Slc6a6/TauT-mediated uptake of [3H]GABA by more than
70%. In contrast, L-leucine and L-alanine had no signiﬁcant effect on
Slc6a6/TauT-mediated uptake of [3H]GABA. Moreover, the absence of
either Na+ or Cl− reduced the Slc6a6/TauT-mediated uptake of [3H]
GABA bymore than 90% (Fig. 2B). These characteristics of Slc6a6/TauT-
mediated uptake of GABA are consistent with those of taurine [7,17].
3.2. GABA transport system in TR-iBRB2 cells
[3H]GABAuptakewas performed using TR-iBRB2 cells as an in vitro
model of the inner BRB in order to determine the kinetic parameters of
GABA and characterize GABA transport at the inner BRB. The time-
course of [3H]GABA uptake by TR-iBRB2 cells is shown in Fig. 3A. [3H]
GABA uptake increased linearly for 10 min and the initial uptake rate
was 8.45 fmol/(min·mg protein). In contrast, [3H]GABA uptake was
reduced by 89.6% and 89.5% in the absence of either Na+ or Cl−,
respectively (Fig. 3B), suggesting that GABA uptake by TR-iBRB2 cells
takes place in an Na+-, and Cl−-dependent manner.
The effect of amino acids and an organic anion on [3H]GABA uptake
by TR-iBRB2 cells is summarized in Table 3. Taurine and β-alanine at a
concentration of 2 mM markedly inhibited [3H]GABA uptake by more
than 80%. GABA at a concentration of 2 mM inhibited [3H]GABA uptake
by 61%. Nipecotic acid inhibited [3H]GABA uptake by 17% and 54% at a
concentration of 500 μM and 2 mM, respectively. Betaine, L-leucine, L-
alanine, and creatine at a concentration of 2mMhad aweaker effect and
2 mM probenecid had no signiﬁcant effect on [3H]GABA uptake. The
uptake of GABA by TR-iBRB2 cells was concentration-dependent with a
Km and Jmax of 2.04±0.33 mM and 5.80±0.53 nmol/(min·mg protein)
(mean±S.D.), respectively (Fig. 3C). Moreover, the Eadie–Scatchard plot
showed that the two lines of theGABAuptake in thepresence or absence
of 50 μM taurine intersected on the abscissa. This indicates that tau-
rine competitively inhibited GABA uptake with a Ki of 73.8±8.8 μM
(mean±S.D.) (Fig. 4A). In the presence of 5 mM of GABA, [3H]taurine
uptake by TR-iBRB2 cells also exhibited competitive inhibitionwith a Ki
of 1.80±0.01 mM (mean±S.D.) (Fig. 4B). These results conﬁrm the
presence of Slc6a6/TauT-mediated uptake of GABA in TR-iBRB2 cells.
4. Discussion
The present study demonstrates that rat Slc6a6/TauT-transfected
HeLa cells exhibit Na+, Cl−, and concentration-dependent GABAuptake
(Fig. 2). It has been reported that transfection with rat Slc6a6/TauT
into COS cells did not result in enhanced uptake of [3H]GABA [7]. These
controversial observations suggest that Slc6a6/TauT-mediated GABA
transport activity depends on the cell type and preparation used.The crystal structure of a bacterial homolog of Slc6 transporter from
Aquifex aeolicus (leucine transporter; LeuTAa) predicts that 12 residues in
transmembrane segments1, 3, 6, and8are involved in substratebinding in
Slc6 transporters [18]. Creatine transporter (Slc6a8/CRT) is reported to lose
creatine transport activity and gain a GABA transport function by com-
binations of 2 or 3 amino acid substitutions at the 12 residues involved in
substrate binding with their counterpart in Slc6a1/GAT-1 [19]. The amino
acid sequence alignmentof rat Slc6a6/TauT, Slc6a11/GAT-3, Slc6a12/BGT-1,
and Slc6a13/GAT-2 at the 12 residues involved in substrate binding
showed that only 3 of the 12 residues in Slc6a6/TauT are different from
those in Slc6a11/GAT-3, Slc6a12/BGT-1, and Slc6a13/GAT-2, implying that
the substrate binding sites of Slc6a6/TauTare capable of recognizingGABA
as a substrate. On the other hand, the substitution of glutamate-61 of
mouse Slc6a11/GAT4, one of the 3 amino acid differences in the 12
residues involved in substrate binding, with its Slc6a6/TauT counterpart
glycine markedly increased the inhibitory potency of taurine on the
uptake of [3H]GABA [20]. This evidence suggests that the 3 amino acid
differences in the 12 residues involved in substrate binding play a key role
in high-afﬁnity transport of taurine in Slc6a6/TauT.
We have recently reported that Slc6a6/TauT is expressed and pre-
dominantly involved in taurine transport in rat retinal capillary en-
dothelial cells (TR-iBRB2) [6]. The uptake of [3H]GABA by TR-iBRB2 cells
took place in an Na+-, Cl−-, and concentration-dependent manner (Fig. 3).
The corresponding Km of 2.0 mM (Fig. 3C) is in good agreement with that
obtained for GABA uptake by rat Slc6a6/TauT expressed HeLa cells
(Km=1.5 mM) (Fig. 2C) but is much higher than those in other GABA
transporters [13–16] (Table 1). Typical Slc6a6/TauT substrates, such as
2142 M. Tomi et al. / Biochimica et Biophysica Acta 1778 (2008) 2138–2142taurine and β-alanine, strongly inhibited [3H]GABA uptake by TR-iBRB2
cells (Table 3). These formsof inhibitionare consistentwith thoseobtained
for [3H]GABA uptake by rat Slc6a6/TauT expressed HeLa cells (Table 2).
Inhibitory effect of nipecotic acid on [3H]GABA uptake by TR-iBRB2 cells
(Table 3) was much less than those observed in mouse Slc6a1/GAT1,
Slc6a11/GAT4, and Slc6a13/GAT3 [21]. Betaine, a speciﬁc substrate of
Slc6a12/BGT-1 [16,21], produced no marked inhibition of this process
(Table 3). Furthermore, mutual inhibition was observed for GABA and
taurine uptake by TR-iBRB2 cells. The [3H]GABAuptakewas competitively
inhibited by 50 μM taurine with a Ki of 74 μM (Fig. 4A), which is com-
parablewith theKm of 22 μM for taurine uptake by TR-iBRB2 cells [6]. The
[3H]taurineuptakewas also competitively inhibited by 5mMGABAwith a
Ki of 1.8 mM (Fig. 4B), which is comparable with the Km of 2.0 mM for
GABAuptake by TR-iBRB2 cells (Fig. 3C). These results suggest that Slc6a6/
TauT plays a key role in the transport of GABA as well as taurine at the
inner BRB. Although the physiological relevance of Slc6a6/TauTas a GABA
transporter is not revealed as extracellular concentrations of GABA and
taurine in the retina are unknown, the low-afﬁnity GABA transport via
Slc6a6/TauT might make a greater contribution to the removal of GABA
from retinal interstitial ﬂuidwhen GABA is released from the intracellular
spaces under hyposmosis and ischemia [22].
In conclusion, the data presented here provides the ﬁrst evidence
that GABA is actually a substrate of Slc6a6/TauT. Slc6a6/TauT appears
to play a key role in transporting GABA at the inner BRB. These
ﬁndings provide important information to increase our understanding
of the substrate binding mechanisms of Slc6 transporters and the
physiological roles of GABA transporters in neural tissues.
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